Airway Epithelium Gene Expression: AEGIS IDE
NCT00746759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1331
Last updated 2015-06-04
Summary
The purpose of the research study is to develop a new, more sensitive, and less invasive test for diagnosing lung cancer at an earlier stage, when it can more easily be cured. The investigators hypothesize that certain genes are expressed differently in current and former smokers who have lung cancer, and this difference in gene expression may be a biomarker for lung cancer.
Conditions
Interventions
- DEVICE
-
Biomarker (not used as an intervention)
This study is an observational study. There is no intervention.
Sponsors & Collaborators
- collaborator OTHER
- collaborator OTHER
-
Temple University
collaborator OTHER -
Indiana University
collaborator OTHER -
University of Alabama at Birmingham
collaborator OTHER -
University of Missouri-Columbia
collaborator OTHER -
Louisiana State University Health Sciences Center in New Orleans
collaborator OTHER -
University of Wisconsin, Madison
collaborator OTHER -
Medical University of South Carolina
collaborator OTHER -
National Jewish Health
collaborator OTHER -
Overlake Hospital Bellevue WA
collaborator UNKNOWN -
Pulmonary and Allergy Associates of New Jersey
collaborator UNKNOWN -
Pulmonary Associates of Arizona
collaborator UNKNOWN -
William Jennings Bryan Dorn VA Medical Center
collaborator FED -
Virginia Commonwealth University
collaborator OTHER -
Jamaica Hospital Medical Center
collaborator OTHER -
North Florida/South Georgia Veterans Health System
collaborator OTHER -
Steward St. Elizabeth's Medical Center of Boston, Inc.
collaborator OTHER -
University of California, Davis
collaborator OTHER -
Yale University
collaborator OTHER -
The Cleveland Clinic
collaborator OTHER -
Allegro Diagnostics, Corp.
lead INDUSTRY
Principal Investigators
-
Duncan Whitney, PhD · Allegro Diagnostics
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2014-12-31
- Completion
- 2015-02-28
Countries
- United States
Study Locations
More Related Trials
-
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
NCT01830426 ·Status: COMPLETED
-
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00450281 ·Status: COMPLETED
-
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
NCT06816121 ·Status: RECRUITING
-
DNA Chip Based Prognosis of Lung Cancer
NCT00973427 ·Status: COMPLETED
-
Liquid Biopsy for Early Non-small Lung Cancer Detection
NCT05462795 ·Status: COMPLETED
-
Incorporation of Genetic Expression of Airway Epithelium With CT Screening for Lung Cancer
NCT01982149 ·Status: TERMINATED
-
Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
NCT00607425 ·Status: TERMINATED
-
Nashville Early Diagnosis Lung Cancer Project
NCT01475500 ·Status: ACTIVE_NOT_RECRUITING
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay
NCT03558165 ·Status: COMPLETED
-
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
NCT01700257 ·Status: COMPLETED ·Phase: NA
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
NCT07009769 ·Status: COMPLETED
-
Liquid Biopsy Using Methylation Sequencing for Lung Cancer
NCT04253509 ·Status: COMPLETED
-
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NCT05384769 ·Status: RECRUITING ·Phase: NA
-
Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer
NCT07042867 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients
NCT03236675 ·Status: UNKNOWN
-
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
NCT00340847 ·Status: COMPLETED
-
An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions
NCT03535766 ·Status: COMPLETED
-
Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
NCT06577883 ·Status: RECRUITING
-
Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer
NCT00002667 ·Status: COMPLETED ·Phase: NA
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Early Detection of Lung Cancer
NCT03181256 ·Status: ACTIVE_NOT_RECRUITING